Justin T. Jordan

Also affiliated with The University of Texas Southwestern Medical Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

(2023)10.1158/1078-0432.c.6530168

Top 100%

0DataRank

Top 100%0 citations

Annette M. Molinaro, Katherine B. Peters, Jennifer Clarke, Justin T. Jordan, John de Groot +17 more

Papers

Driven by 19 papers — median percentile 0. Top paper: “Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial”.

Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial

Blood(2022)10.1182/blood.2021014738

N/A

4.5DataRank · unranked

141 citations

Jörg Dietrich, Kathleen Gallagher, Mark Roschewski, Justin T. Jordan, Deborah Forst +22 more

Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network

The Oncologist(2022)10.1093/oncolo/oyac134

N/A

0.867DataRank · unranked

22 citations

Rebecca S. Heist, Adam Z. Bard, Annacarolina F L da Silva, Ibiayi Dagogo‐Jack, Valentina Nardi +45 more

Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation

Genetics in Medicine(2022)10.1016/j.gim.2022.05.007

N/A

0.846DataRank · unranked

281 citations

Ludwine Messiaen, Eric Legius, Patrice Pancza, Robert A. Avery, Jaishri O. Blakeley +79 more

Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2500

N/A

0.835DataRank · unranked

261 citations

Annette M. Molinaro, Katherine B. Peters, Jennifer Clarke, Justin T. Jordan, John de Groot +17 more

Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA

Cancer Discovery(2023)10.1158/2159-8290.cd-22-0786

N/A

0.681DataRank · unranked

93 citations

Christopher D. Steele, Katherine Piculell, Alyaa Al‐Ibraheemi, Vanessa Eulo, Marilyn M. Bui +26 more

A rapid genotyping panel for detection of primary central nervous system lymphoma

Blood(2021)10.1182/blood.2020010137

N/A

0.564DataRank · unranked

42 citations

Evan Burns, N. Zeke Georgantas, Julia Thierauf, Naema Nayyar, Amanda Gordon +24 more

DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI

IEEE Journal of Biomedical and Health Informatics(2021)10.1109/jbhi.2021.3087735

N/A

0.492DataRank · unranked

10 citations

Wei Chen, K. Ina Ly, Xubin Zhang, Fan Yan, Justin T. Jordan +5 more

ACR Appropriateness Criteria® Brain Tumors

Journal of the American College of Radiology(2025)10.1016/j.jacr.2025.02.036

N/A

0.360DataRank · unranked

10 citations

Robert Shih, Pallavi S. Utukuri, Amna A. Ajam, Moisés Aurón, Susan M. Chang +12 more

Multi-center, single arm phase II study of the dual mTORC1/mTORC2 inhibitor vistusertib for patients with recurrent or progressive grade II-III meningiomas.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2024

N/A

0.345DataRank · unranked

9 citations

Priya Kumthekar, Patrick Y. Wen, Frederick G. Barker, Anat Stemmer‐Rachamimov, Roberta L. Beauchamp +4 more

Prognostic significance of O6-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase-mutant glioma

Neuro-Oncology(2025)10.1093/neuonc/noaf287

N/A

0.241DataRank · unranked

4 citations

Elisa Aquilanti, Julie J. Miller, Zhou Lan, Aleksandra B Lasica, Isabel Arrillaga‐Romany +20 more

COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis

medRxiv(2022)10.1101/2022.03.31.22273208

N/A

0DataRank · unranked

0 citations

Jan M. Friedman, Laura J. Klesse, Kaleb Yohay, Justin T. Jordan, Scott R. Plotkin +3 more

The Brain Health Imperative in the 21st Century—A Call to Action

Neurology(2023)10.1212/wnl.0000000000207739

N/A

0DataRank · unranked

85 citations

Joel Salinas, Justin T. Jordan, Brenda Banwell, Daniel J. Correa, Rana Said +4 more

Vestibular dysfunction in NF2–related schwannomatosis

Brain Communications(2023)10.1093/braincomms/fcad089

N/A

0DataRank · unranked

9 citations

Susan King, Jennifer Zhu, Faisal Karmali, D. Bradley Welling, Wenli Cai +3 more

Proteasomal pathway inhibition as a potential therapy for NF2-associated meningioma and schwannoma

Neuro-Oncology(2023)10.1093/neuonc/noad037

N/A

0DataRank · unranked

10 citations

Janet L. Oblinger, Roberta L. Beauchamp, Zhenzhen Yin, Serkan Erdin, Priya Koundinya +8 more

Data from Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

(2023)10.1158/1078-0432.c.6530168

Top 100%

0DataRank

Top 100%0 citations

Annette M. Molinaro, Katherine B. Peters, Jennifer Clarke, Justin T. Jordan, John de Groot +17 more

Data from Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

(2023)10.1158/1078-0432.c.6530168.v1

Top 100%

0DataRank

Top 100%0 citations

Annette M. Molinaro, Katherine B. Peters, Jennifer Clarke, Justin T. Jordan, John de Groot +17 more

Integrating Ataxia Evaluation into Tumor-Induced Hearing Loss Model to Comprehensively Study NF2-Related Schwannomatosis

Cancers(2024)10.3390/cancers16111961

N/A

0DataRank · unranked

4 citations

Zhenzhen Yin, Jie Chen, Limeng Wu, Yao Sun, Xing Gao +5 more

Awareness and Agreement with Neurofibromatosis Care Guidelines among Neurofibromatosis Specialists

medRxiv(2021)10.1101/2021.06.16.21259047

N/A

0DataRank · unranked

0 citations

Pamela Knight, Heather B. Radtke, Kaleb Yohay, Nicole J. Ullrich, Scott R. Plotkin +2 more

mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition

Journal of Biological Chemistry(2020)10.1074/jbc.ra120.014960

N/A

0DataRank · unranked

18 citations

Serkan Erdin, Luke Witt, Justin T. Jordan, Scott R. Plotkin, James F. Gusella +2 more

Justin T. Jordan

Indexed papers

Top data-sharing exemplar

Papers